This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4ef8
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:4ef8.jpg|left|200px]] | ||
| - | |||
{{STRUCTURE_4ef8| PDB=4ef8 | SCENE= }} | {{STRUCTURE_4ef8| PDB=4ef8 | SCENE= }} | ||
| - | |||
===Crystal structure of dihydroorotate dehydrogenase from Leishmania major in complex with Phenyl isothiocyanate=== | ===Crystal structure of dihydroorotate dehydrogenase from Leishmania major in complex with Phenyl isothiocyanate=== | ||
| - | |||
{{ABSTRACT_PUBMED_23116399}} | {{ABSTRACT_PUBMED_23116399}} | ||
==About this Structure== | ==About this Structure== | ||
[[4ef8]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Leishmania_major Leishmania major]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4EF8 OCA]. | [[4ef8]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Leishmania_major Leishmania major]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4EF8 OCA]. | ||
| - | + | ||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:023116399</ref><references group="xtra"/><references/> | ||
[[Category: Leishmania major]] | [[Category: Leishmania major]] | ||
[[Category: Emery, F S.]] | [[Category: Emery, F S.]] | ||
Revision as of 06:33, 20 June 2013
Crystal structure of dihydroorotate dehydrogenase from Leishmania major in complex with Phenyl isothiocyanate
Template:ABSTRACT PUBMED 23116399
About this Structure
4ef8 is a 2 chain structure with sequence from Leishmania major. Full crystallographic information is available from OCA.
Reference
- Pinheiro MP, Emery FD, Nonato MC. Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate. Curr Pharm Des. 2012 Oct 31. PMID:23116399
